By characterizing for the first time the APL metabolic background, we demonstrate that PML::RARα inhibits glycolysis via AKT degradation, promotes TCA, and favors LCFA catabolism, exposing APL cells to strong dependency and vulnerabilities to OXPHOS inhibition. The gene discussed is RARA; the disease is acute promyelocytic leukemia.